ZA200802953B - Solid vaccine formulation - Google Patents
Solid vaccine formulationInfo
- Publication number
- ZA200802953B ZA200802953B ZA200802953A ZA200802953A ZA200802953B ZA 200802953 B ZA200802953 B ZA 200802953B ZA 200802953 A ZA200802953 A ZA 200802953A ZA 200802953 A ZA200802953 A ZA 200802953A ZA 200802953 B ZA200802953 B ZA 200802953B
- Authority
- ZA
- South Africa
- Prior art keywords
- vaccine formulation
- solid vaccine
- solid
- formulation
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200501392 | 2005-10-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200802953B true ZA200802953B (en) | 2009-01-28 |
Family
ID=35602348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200802953A ZA200802953B (en) | 2005-10-04 | 2008-04-03 | Solid vaccine formulation |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101296705A (en) |
BR (1) | BRPI0616879A2 (en) |
ZA (1) | ZA200802953B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2558120A4 (en) * | 2010-04-15 | 2013-08-28 | Shin Nippon Biomedical Lab Ltd | Methods and compositions for intranasal delivery |
JP6110845B2 (en) * | 2011-05-17 | 2017-04-05 | ザ リージェント オブ ザ ユニバーシティー オブ コロラド、ア ボディー コーポレート | Heat resistant vaccine composition and method for preparing the same |
WO2014100860A2 (en) * | 2012-12-28 | 2014-07-03 | Cellestis Limited | A cell mediated immune response assay |
WO2017090766A1 (en) * | 2015-11-27 | 2017-06-01 | 日東電工株式会社 | Vaccine pharmaceutical composition for oral administration and method for manufacturing vaccine pharmaceutical composition for oral administration |
JP7339886B2 (en) * | 2016-11-21 | 2023-09-06 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | Liquid allergen composition and method for producing the same |
JOP20200140A1 (en) | 2017-12-07 | 2022-10-30 | Merck Sharp & Dohme | Formulations of dengue virus vaccine compositions |
-
2006
- 2006-10-04 BR BRPI0616879-5A patent/BRPI0616879A2/en not_active IP Right Cessation
- 2006-10-04 CN CNA2006800403788A patent/CN101296705A/en active Pending
-
2008
- 2008-04-03 ZA ZA200802953A patent/ZA200802953B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0616879A2 (en) | 2011-07-05 |
CN101296705A (en) | 2008-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200708634B (en) | Novel vaccine formulations | |
IL192084A0 (en) | Vaccine | |
GB0504436D0 (en) | Vaccine | |
GB0505909D0 (en) | Formulations | |
IL186828A0 (en) | Vaccine composition | |
EP1909584A4 (en) | Prenylflavonoid formulations | |
GB0526419D0 (en) | Formulation | |
GB0505569D0 (en) | Formulations | |
GB0517673D0 (en) | Formulation | |
ZA200802953B (en) | Solid vaccine formulation | |
GB0515135D0 (en) | Vaccine | |
GB0501030D0 (en) | Formulation | |
GB0504940D0 (en) | Vaccine formulation | |
ZA200709207B (en) | Vaccine | |
LT1928232T (en) | Solid formulation | |
GB0516944D0 (en) | Vaccine | |
GB0810662D0 (en) | Vaccine | |
ZA200709210B (en) | Vaccine | |
GB0526412D0 (en) | Vaccine | |
GB0502569D0 (en) | Vaccine composition | |
GB0500807D0 (en) | Formulation | |
GB0507811D0 (en) | Formulation | |
GB0510788D0 (en) | Formulation | |
GB0513194D0 (en) | Vaccine | |
GB0526232D0 (en) | Vaccine |